» Articles » PMID: 30795972

Is Resolution the End of Inflammation?

Overview
Journal Trends Mol Med
Date 2019 Feb 24
PMID 30795972
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

Deciphering the origins of chronic inflammatory and autoimmune diseases remains elusive with reliance on therapies aimed at halting inflammation in its tracks. In recent years, an appreciation of targeting pathways by which inflammation is resolved has begun to rouse interest. Resolution of inflammation is driven by a complex set of mediators that regulate cellular events required to clear inflammatory cells from sites of infection or injury to restore tissue function. However, recent studies suggest that resolution is not the end of innate mediated immune responses to infection/injury. There is further immunological activity occurring after the resolution cascade is complete that alters the immune physiology of tissues, redefining what was once termed restorative homeostasis as adapted homeostasis.

Citing Articles

Potential role of NSAIDs loaded nano-formulations to treat inflammatory diseases.

Zahoor I, Bala R, Wani S, Chauhan S, Madaan R, Kumar R Inflammopharmacology. 2025; .

PMID: 39953360 DOI: 10.1007/s10787-025-01644-x.


Selected Plant Extracts Regulating the Inflammatory Immune Response and Oxidative Stress: Focus on .

Nehme R, Chervet A, Decombat C, Habanjar O, Longechamp L, Rousset A Nutrients. 2025; 17(3).

PMID: 39940368 PMC: 11820342. DOI: 10.3390/nu17030510.


Vascularization, Innervation, and Inflammation: Pathways Connecting the Heart-Brain Axis and Implications in a Clinical Setting.

Lauinger A, Sepe J Biomedicines. 2025; 13(1).

PMID: 39857755 PMC: 11762153. DOI: 10.3390/biomedicines13010171.


Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis.

Batarfi W, Mohd Yunus M, A Hamid A, Lee Y, Maarof M Pharmaceutics. 2025; 16(12.

PMID: 39771483 PMC: 11728517. DOI: 10.3390/pharmaceutics16121504.


Anti-Inflammatory Effects of Extracellular Vesicles from on 12-O-Tetradecanoylphorbol-13-Acetate-Induced Skin Inflammation in Mice.

Kim G, Lee S, Oh S, Jang J, Lee J, Kim H Int J Mol Sci. 2024; 25(23).

PMID: 39684233 PMC: 11641720. DOI: 10.3390/ijms252312522.